Welcome to our dedicated page for PRO DEX SEC filings (Ticker: PDEX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on PRO DEX's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into PRO DEX's regulatory disclosures and financial reporting.
Pro Dex Inc director Angelita Rebamontan acquired 19 shares of common stock on July 23, 2026 at $33.25 per share through an Employee Stock Purchase Plan in transactions exempt under Rule 16b-3(c) and Rule 16b-3(d). After this acquisition, she directly holds 18,798 shares.
Pro-Dex Inc director Domingo Angelita Rebamontan reported an open-market sale of 998 shares of Common Stock on March 16, 2026, at $47.2400 per share. Following this transaction, the director directly holds 18,779 shares of Pro-Dex common stock.
PRO DEX INC Chief Financial Officer Alisha Charlton reported equity compensation activity rather than open-market trading. She received 10,800 shares of common stock at a stated price of $0.00 per share under a performance award agreement. On the same date, 3,897 shares were withheld at $62.74 per share to cover her tax obligations. After these transactions, she directly holds 24,170 shares of PRO DEX INC common stock.
PRO DEX INC director Angelita Rebamontan reported routine equity compensation activity. On a grant/award basis, she acquired 6,800 shares of Common Stock at $0.00 per share under a performance award agreement pursuant to the Pro-Dex, Inc. 2016 Equity Incentive Plan.
On the same date, 2,488 shares were disposed of at $62.74 per share to satisfy her tax withholding obligations, a non-market tax-withholding transaction. After these entries, she directly holds 19,777 shares of Common Stock.
PRO DEX INC Chief Executive Officer Richard Lee Van Kirk Jr reported compensation-related stock transactions. He received 14,800 shares of Common Stock as a grant under a performance award agreement pursuant to the Pro-Dex, Inc. 2016 Equity Incentive Plan. To cover tax obligations, 5,279 shares were withheld, which is recorded as a tax-withholding disposition rather than an open-market sale. Following these transactions, he directly holds 99,228 shares of PRO DEX INC common stock.
AO Partners Group and Nicholas J. Swenson filed an amended Schedule 13D disclosing a large ownership stake in Pro-Dex, Inc. common stock. Swenson beneficially owns 1,017,817 shares, representing 31.88% of the 3,192,759 shares outstanding as of April 30, 2026, through AO Partners I, L.P., AO Partners, LLC, Groveland DST LLC, and personal holdings.
The group acquired shares in open market purchases using $2,032,015 of AO Partners Fund working capital and Swenson’s personal capital because it believes Pro-Dex stock is undervalued and intends to influence company policies and assert shareholder rights to maximize value. AO Partners Fund has 922,204 shares and Groveland DST 34,316 shares; Swenson holds 61,297 shares directly.
The filing notes that AO Partners Fund has pledged 922,204 shares and Swenson has pledged 61,170 shares as collateral for bank loans obtained in the ordinary course of business. The group indicates it may buy more or sell shares in the future and acknowledges that its actions may constitute a control purpose under securities regulations.
Pro-Dex, Inc. furnished an investor presentation to investors and analysts, identified as Exhibit 99.1, beginning June 17, 2026. The slideshow is expected to be used, with possible modifications, in presentations to investors, analysts and others during the remainder of calendar year 2026.
The company notes that the presentation should be read together with its other SEC filings and public announcements. The information in the investor presentation and this 8-K Item 7.01 is being furnished, not filed, so it is not automatically subject to certain Exchange Act liabilities.
PRO DEX INC Chief Executive Officer Richard Lee Van Kirk Jr reported selling 10,000 shares of common stock in open-market transactions on May 21–22, 2026. The reported sale prices ranged from about $61.55 to $64.33 per share, based on weighted average prices disclosed.
These transactions were executed under a pre-arranged Rule 10b5-1 trading plan adopted on February 19, 2026, indicating they were scheduled in advance. Following the sales, he directly owns 89,707 shares of PRO DEX INC common stock.
Pro-Dex, Inc. reported higher sales and earnings for its fiscal third quarter and nine months ended March 31, 2026. Third-quarter net sales rose 15% to $19.9 million from $17.4 million, driven mainly by higher shipments of its largest customer’s next generation orthopedic handpiece, partly offset by lower repair revenue. Gross profit increased to $6.1 million, but gross margin slipped to 31% from 33% on a less favorable product mix. Operating expenses climbed 41% to $3.0 million, reflecting the Advanced Precision Machining acquisition and higher personnel costs, reducing operating income to $3.1 million from $3.6 million.
Third-quarter net income rose to $3.9 million, or $1.20 per diluted share, from $3.3 million, or $0.98, boosted by a $2.3 million realized gain on contingent value rights tied to Monogram Technologies. For the nine months, net sales increased 16% to $57.1 million, and net income grew to $10.8 million, or $3.27 per diluted share, aided by a $9.1 million realized gain partly offset by reversal of $3.2 million in prior unrealized gains. Cash and cash equivalents rose to $10.0 million and shareholders’ equity to $45.2 million as of March 31, 2026.